Anti-telomerase vaccine in patients with newly diagnosed, unmethylated MGMT glioblastoma: A phase II study

被引：0
|
作者：
Carpentier, Antoine F.
Verlut, Clotilde
Ghiringhelli, Francois
Bronnimann, Charlotte
Ursu, Renata
Fumet, Jean David
Gherga, Elisabeta
Lefort, Felix
Belin, Catherine
Vernerey, Dewi
Hervieu, Alice
Laheurte, Caroline
Meurisse, Aurelia
Jacquin, Marion
Malfroy, Marine
Fagnoni-Legat, Christine
Lehmann-Che, Jacqueline
Boullerot, Laura
Cuzzubbo, Stefania
Adotevi, Olivier
机构：
[1] Hop St Louis, Paris, France
[2] Univ Hosp Besancon, Dept Neurol, F-25000 Besancon, France
[3] Ctr GF LECLERC, Early Clin Unit CLIP2 INCA, Dijon, France
[4] Hop St Andre, Bordeaux, France
[5] St Louis Hosp, AP HP, Dept Neurol, Paris, France
[6] UNICANCER, Georges Francois Leclerc Canc Ctr, Dijon, France
[7] Hop Nord Franche Comte, Dept Radiotherapy, Montbeliard, France
[8] Univ Bordeaux, Dept Med Oncol, Hop St Andre, CHU Bordeaux, Bordeaux, France
[9] Paris Cite Univ, Dept Neurol, St Louis Hosp, AP HP, Paris, France
[10] UMQVC, Besancon, France
[11] Univ Hosp Besancon, Besancon, France
[12] Ctr Georges Francois Leclerc, Dijon, France
[13] Univ Franche Comte, INSERM, EFS UFC, UMR1098,RIGHT, Besancon, France
[14] CHU Jean Minjoz Besancon, Besancon, France
[15] Univ Hosp Besancon, INSERM CIC 1431, Clin Invest Ctr, Besancon, France
[16] Univ Bourgogne Franche Comte, INSERM, EFS BFC, RIGHT,UMR1098, Besancon, France
[17] Univ Hosp Besancon, Dept Pharm, Besancon, France
[18] St Louis Hosp Paris, Paris, France
[19] Univ Hosp Besancon, Dept Med Oncol, Besancon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2005
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE II STUDY OF AZELIRAGON IN COMBINATION WITH RADIATION THERAPY IN NEWLY DIAGNOSED PATIENTS WITH MGMT-UNMETHYLATED GLIOBLASTOMA
    Huang, Jiayi
    Ahluwalia, Manmeet
    Boockvar, John
    Batiste, James
    Jaboin, Jerry
    Thotala, Dinesh
    Halasz, Lia
    Rammohan, Nikhil
    Ney, Douglas
    Malani, Rachna
    Chinnaiyan, Prakash
    Kotecha, Rupesh R.
    Mehta, Minesh
    Marcus, Stephen
    NEURO-ONCOLOGY, 2024, 26
  • [2] UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM
    Carpentier, A. F.
    Verlut, C.
    Ghiringhelli, F.
    Bronnimann, C.
    Ursu, R.
    Fumet, J.
    Gherga, E.
    Lefort, F.
    Belin, C.
    Vernerey, D.
    Larroquette, M. Mathieu
    Hervieu, A.
    Laheurte, C.
    Meurisse, A.
    Jacquin, M.
    Malfroy, M.
    Kroemer, M.
    Clairet, A.
    Fagnoni-Legat, C.
    Lehmann-Che, J.
    Boullerot, L.
    Cuzzubbo, S.
    Adotevi, O.
    NEURO-ONCOLOGY, 2023, 25
  • [3] Pharmacokinetics and pharmacodynamics of paxalisib in newly diagnosed glioblastoma patients with unmethylated MGMT promoter status: Final phase II study results
    Wen, P.
    De Groot, J. F.
    Battiste, J.
    Goldlust, S.
    Damek, D.
    Ellingson, B.
    Garner, J.
    Friend, J.
    Simpson, J.
    Olivero, A.
    Cloughesy, T.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S667 - S667
  • [4] Paxalisib in patients with newly diagnosed glioblastoma with unmethylated MGMT promoter status: Final phase 2 study results
    Wen, Patrick Y.
    De Groot, John Frederick
    Battiste, James
    Goldlust, Samuel A.
    Garner, James Stuart
    Friend, John
    Simpson, Jeremy Andrew
    Damek, Denise
    Olivero, Alan
    Cloughesy, Timothy Francis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Phase I/II study of dianhydrogalactitol (VAL-083) with radiation therapy in patients with newly diagnosed, MGMT-unmethylated glioblastoma
    Chen, Zhong-ping
    Guo, Chengcheng
    Bacha, Jeffrey
    Langlands, John
    Steino, Anne
    Kwan, Claire
    Kanekal, Sarath
    Schwartz, Richard
    Lopez, Lorena
    Brown, Dennis
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Phase I/II study of dianhydrogalactitol (VAL-083) with radiation therapy in patients with newly diagnosed glioblastoma, MGMT-unmethylated
    Chen, Zhong-ping
    Guo, Chengcheng
    Bacha, Jeffrey
    Steino, Anne
    Langlands, John
    Kwan, Claire
    Kanekal, Sarath
    Schwartz, Richard
    Lopez, Lorena
    Brown, Dennis M.
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
    Faye, Mame Daro
    Easaw, Jacob
    De Robles, Paula
    Agnihotram, Raman
    Torres-Vasquez, Alexander
    Lamonde, Frederic
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Shenouda, George
    Souhami, Luis
    Azam, Maryam
    Hossain, Bushra
    Alkass, Jad
    Sabri, Siham
    Abdulkarim, Bassam
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [8] PHASE 1/2 STUDY OF DIANHYDROGALACTITOL (VAL-083) WITH RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED, MGMT-UNMETHYLATED GLIOBLASTOMA
    Chen, Zhong-ping
    Guo, Chengcheng
    Bacha, Jeffrey
    Steino, Anne
    Langlands, John
    Kwan, Claire
    Kanekal, Sarath
    Schwartz, Richard
    Lopez, Lorena
    Brown, Dennis
    NEURO-ONCOLOGY, 2018, 20 : 27 - 27
  • [9] Cilengitide in patients with newly diagnosed glioblastoma multiforme and unmethylated MGMT gene promoter: Protocol of a multicenter, randomized, open-label, controlled phase II study
    Nabors, L. B.
    Fink, K.
    Reardon, D. A.
    Lesser, G. J.
    Trusheim, J.
    Raval, S. N.
    Hicking, C.
    Picard, M.
    Mikkelsen, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIATION IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA
    Majd, Nazanin
    Yeboa, D. Nana
    Weathers, Shiao-Pei
    Yuan, Ying
    Robichaux, Christine
    Al Anssari, Haider
    Gachimova, Evguenia
    Loghin, Monica
    Kamiya-Matsuoka, Carlos
    O'Brien, Barbara
    Aaroe, Ashley
    Patel, Chirag
    Yung, W. K. Alfred
    Wintermark, Max
    Gule, Maria
    Ferguson, Sherise
    Puduvalli, Vinay
    de Groot, John
    NEURO-ONCOLOGY, 2023, 25
12345